Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

Extendicare Announces Timing of 2017 Third Quarter Results and Conference Call




These press releases may also interest you

at 13:00
Orig3n, a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine, today announced that its co-founders, Robin Y. Smith, CEO, and Kate Blanchard, COO, are finalists for the Ernest and Young Entrepreneur...

at 13:00
The "Infantile Spasms Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global infantile spasms therapeutics market to...

at 13:00
Members of the Union of Canadian Correctional Officers (UCCO-SACC-CSN) will be demonstrating on Monday, June 25, in front of the office of Ginette Petitpas Taylor, Canada's Minister of Health. The correctional officers are asking the government to...

at 13:00
Mezzion Pharma and the National Heart, Lung, and Blood Institute (NHLBI) today announced that it has completed enrollment of their FUEL trial, a pivotal Phase 3 efficacy and safety trial of udenafil for the treatment of adolescents with congenital...

at 12:51
Unable to carry signals based on sights and sounds to the genes that record memories, a broken shuttle protein may hinder learning in patients with intellectual disability, schizophrenia, and autism. This is the...

at 12:47
FSD Pharma Inc. ("FSD" or the "Company") , welcomes the official passing of Bill C-45, the Cannabis Act in Canada. Bill C-45 formally received Royal Assent Thursday morning in Canada's Parliament. The bill officially...




News published on 6 october 2017 at 07:03 and distributed by: